Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-10,400
Closed -$1K 1290
2023
Q1
$1K Sell
10,400
-77,900
-88% -$84.9K ﹤0.01% 1118
2022
Q4
$2K Sell
88,300
-22,600
-20% -$35.2K ﹤0.01% 1367
2022
Q3
$7K Sell
110,900
-31,600
-22% -$78.7K ﹤0.01% 1395
2022
Q2
$12K Sell
142,500
-64,900
-31% -$155K ﹤0.01% 1445
2022
Q1
$45K Buy
207,400
+22,300
+12% +$78.4K ﹤0.01% 1300
2021
Q4
$78K Buy
185,100
+54,100
+41% +$409K ﹤0.01% 1311
2021
Q3
$119K Buy
131,000
+35,600
+37% +$261K ﹤0.01% 1208
2021
Q2
$94K Buy
95,400
+66,200
+227% +$559K ﹤0.01% 1237
2021
Q1
$38K Buy
+29,200
New +$194K ﹤0.01% 1244

Other funds holding OCGN

HAP Trading's OCGN Position: Q4 2021 in Review

HAP Trading sold out of Ocugen (OCGN) in Q4 2021, closing a stake of 31,801 shares — an estimated $240K sold.

HAP Trading first reported a position in OCGN in Q2 2021 and held it in 2 quarters. The position peaked at $275K in Q2 2021. 122 funds tracked by Wall St. Rank hold OCGN as of Q4 2021.

  • HAP Trading reported no remaining Ocugen position as of Q4 2021 after selling out during the quarter.
  • HAP Trading sold 31,801 Ocugen shares in Q4 2021, an estimated $240K.
  • HAP Trading first reported a position in Ocugen in Q2 2021 and held it in 2 quarters.
  • HAP Trading's Ocugen position peaked at $275K in Q2 2021.
  • 122 funds tracked by Wall St. Rank held Ocugen as of Q4 2021.

Based on HAP Trading's 13F filing for Q4 2021, filed 14 Feb 2022.